Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study

Lykke Sylow; Mia Klinten Grand; Annika von Heymann; Frederik Persson; Volkert Siersma; Margit Kriegbaum; Christen Lykkegaard Andersen; Christoffer Johansen

doi:10.2337/dc22-0232

Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study

Lykke Sylow^*, Mia Klinten Grand, Annika von Heymann, Frederik Persson, Volkert Siersma, Margit Kriegbaum, Christen Lykkegaard Andersen, Christoffer Johansen

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

10 Citationer (Scopus)

35 Downloads (Pure)

Abstract

For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer on
overall survival.

Originalsprog	Engelsk
Tidsskrift	Diabetes Care
Vol/bind	45
Udgave nummer	6
Sider (fra-til)	e105-e106
Antal sider	2
ISSN	1935-5548
DOI	https://doi.org/10.2337/dc22-0232
Status	Udgivet - 2022

Bibliografisk note

CURIS 2022 NEXS 144

Adgang til dokumentet

10.2337/dc22-0232Licens: Ikke-specificeret

Sylow et al_Diabetes Care_2022_Vol 45(6)_e105-e106Forlagets udgivne version, 3,09 MBLicens: Ikke-specificeret

Citationsformater

Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study. / Sylow, Lykke ; Grand, Mia Klinten; von Heymann, Annika; Persson, Frederik; Siersma, Volkert; Kriegbaum, Margit; Lykkegaard Andersen, Christen ; Johansen, Christoffer.

I: Diabetes Care, Bind 45, Nr. 6, 2022, s. e105-e106.

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

@article{4fa60bfaafd8466c8aa8ed08ed8005bf,

title = "Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study",

abstract = "For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer onoverall survival.",

author = "Lykke Sylow and Grand, {Mia Klinten} and {von Heymann}, Annika and Frederik Persson and Volkert Siersma and Margit Kriegbaum and {Lykkegaard Andersen}, Christen and Christoffer Johansen",

note = "CURIS 2022 NEXS 144",

year = "2022",

doi = "10.2337/dc22-0232",

language = "English",

volume = "45",

pages = "e105--e106",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association",

number = "6",

}

TY - JOUR

T1 - Incidence of new-onset type 2 diabetes after cancer: A Danish cohort study

AU - Sylow, Lykke

AU - Grand, Mia Klinten

AU - von Heymann, Annika

AU - Persson, Frederik

AU - Siersma, Volkert

AU - Kriegbaum, Margit

AU - Lykkegaard Andersen, Christen

AU - Johansen, Christoffer

N1 - CURIS 2022 NEXS 144

PY - 2022

Y1 - 2022

N2 - For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer onoverall survival.

AB - For patients with cancer, prevalent type 2 diabetes at the date of cancer diagnosis is associated with increased cancerspecific and all-cause mortality (1,2). Yet, despite potential health implications, there is limited knowledge on whether cancer is also a risk factor for type 2 diabetes. Moreover, the impact of new-onset type 2 diabetes after cancer diagnosis on survival among cancer patients is unknown. We investigated the incidence of type 2 diabetes following a cancer diagnosis and evaluated the influence of new-onset type 2 diabetes in patients with cancer onoverall survival.

U2 - 10.2337/dc22-0232

DO - 10.2337/dc22-0232

M3 - Letter

C2 - 35653597

VL - 45

SP - e105-e106

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 6

ER -